Lenalidomide Market Key Drivers and Industry Challenges
The rising burden of blood cancers has significantly accelerated the growth of the multiple myeloma treatment market, supported by continuous advancements in the hematologic cancer therapeutics market and the increasing adoption of the immunomodulatory drugs market. Among these therapeutic advancements, lenalidomide has emerged as a cornerstone treatment, playing a crucial role in reshaping...
0 Commentarios 0 Acciones 3 Views 0 Vista previa